Literature DB >> 25451687

Sex-dependent regulation of hepatic CYP3A by growth hormone: Roles of HNF6, C/EBPα, and RXRα.

Jie Li1, Yu Wan2, Shufang Na1, Xiaochan Liu1, Guicheng Dong3, Zheqiong Yang1, Jing Yang1, Jiang Yue4.   

Abstract

Sex-based differences in the pharmacological profiles of many drugs are due in part to the female-predominant expression of CYP3A4, which is the most important CYP isoform responsible for drug metabolism. Transcription factors trigger the sexually dimorphic expression of drug-metabolizing enzymes in response to sex-dependent growth hormone (GH) secretion. We investigated the roles of HNF6, C/EBPα, and RXRα in the regulation of human female-predominant CYP3A4, mouse female-specific CYP3A41, and rat male-specific CYP3A2 expression by GH secretion patterns using HepG2 cells, growth hormone receptor (GHR) knockout mice as well as rat models of orchiectomy and hypophysectomy. The constitutive expression of HNF6 and RXRα was GH-dependent, and GHR deficiency decreased HNF6/C/EBPα complex levels and increased HNF6/RXRα complex levels. Feminine GH secretion induced the binding of HNF6 and C/EBPα to the CYP3A4 and Cyp3a41 promoters and HNF6/C/EBPα complex levels was more efficiently compared with masculine pattern. Additionally, a greater inhibition of the binding of RXRα to the CYP3A4 and Cyp3a41 promoters and HNF6/RXRα complex levels was observed by feminine GH secretion, but less inhibition was observed by masculine pattern. The binding of HNF6, C/EBPα, and RXRα to the CYP3A2 promoter was not directly regulated by androgens. RXRα completely abolished the synergistic activation of the CYP3A4, Cyp3a41, and CYP3A2 promoters by HNF6 and C/EBPα. The results demonstrate that sex-dependent GH secretion patterns affect the expressions and interactions of HNF6, C/EBPα, and RXRα as well as their binding to CYP3A genes. RXRα mediates the sex-dependent influence of GH on CYP3A expression as an important signalling molecule.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug metabolism; Nuclear receptor; Sexually dimorphism; Transcription factor

Mesh:

Substances:

Year:  2014        PMID: 25451687     DOI: 10.1016/j.bcp.2014.10.010

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population.

Authors:  Ya-Li Nie; Hang He; Jiang-Feng Li; Xiang-Guang Meng; Liang Yan; Pei Wang; Shu-Jie Wang; Hong-Zheng Bi; Li-Rong Zhang; Quan-Cheng Kan
Journal:  Eur J Clin Pharmacol       Date:  2016-10-05       Impact factor: 2.953

2.  Sex hormones regulate cerebral drug metabolism via brain miRNAs: down-regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol.

Authors:  Jie Li; Mengmeng Xie; Xiaoshuang Wang; Xiufang Ouyang; Yu Wan; Guicheng Dong; Zheqiong Yang; Jing Yang; Jiang Yue
Journal:  Br J Pharmacol       Date:  2015-08-26       Impact factor: 8.739

3.  Activation of Male Liver Chromatin Accessibility and STAT5-Dependent Gene Transcription by Plasma Growth Hormone Pulses.

Authors:  Jeannette Connerney; Dana Lau-Corona; Andy Rampersaud; David J Waxman
Journal:  Endocrinology       Date:  2017-05-01       Impact factor: 4.736

4.  Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia.

Authors:  Nicole Arguelles; Janielle Richards; Ahmed A El-Sherbeni; Sharon Miksys; Rachel F Tyndale
Journal:  Biochem Pharmacol       Date:  2022-02-07       Impact factor: 6.100

5.  Loganetin protects against rhabdomyolysis-induced acute kidney injury by modulating the toll-like receptor 4 signalling pathway.

Authors:  Jie Li; Yu-Jun Tan; Ming-Zhi Wang; Ying Sun; Guang-Yan Li; Qi-Long Wang; Jing-Chun Yao; Jiang Yue; Zhong Liu; Gui-Min Zhang; Yu-Shan Ren
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

6.  Cross Talk Between GH-Regulated Transcription Factors HNF6 and CUX2 in Adult Mouse Liver.

Authors:  Tara L Conforto; George F Steinhardt; David J Waxman
Journal:  Mol Endocrinol       Date:  2015-07-28

Review 7.  Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer.

Authors:  Ken-ichi Fujita; Yutaro Kubota; Hiroo Ishida; Yasutsuna Sasaki
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

8.  Sex and Estrous Cycle Differences in Analgesia and Brain Oxycodone Levels.

Authors:  Nicole Arguelles; Sharon Miksys; Rachel F Tyndale
Journal:  Mol Neurobiol       Date:  2021-09-28       Impact factor: 5.590

9.  Effect of Pregnane X Receptor*1B genetic polymorphisms on postoperative analgesia with fentanyl in Chinese patients undergoing gynecological surgery.

Authors:  Jing-Jing Yuan; Xiao-Jing Ma; Zhi-Song Li; Yan-Zi Chang; Wei Zhang; Quan-Cheng Kan; Jun-Kai Hou; Li-Rong Zhang
Journal:  BMC Med Genet       Date:  2016-11-23       Impact factor: 2.103

10.  Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα.

Authors:  Ying Sun; Yu-Jun Tan; Zhan-Zhao Lu; Bing-Bing Li; Cheng-Hong Sun; Tao Li; Li-Li Zhao; Zhong Liu; Gui-Min Zhang; Jing-Chun Yao; Jie Li
Journal:  Front Pharmacol       Date:  2018-03-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.